In vitro promotion by alpha4/beta2 nicotinic acetylcholine receptor subtype of neuronal differentiation

被引：0
|
作者：
Takarada, T. [1 ]
Fukumori, R. [1 ]
Nakazato, R. [1 ]
Fujikawa, K. [1 ]
Kou, M. [1 ]
Yoneda, Y. [1 ]
机构：
[1] Kanazawa Univ, Grad Sch, Div Pharmaceut Sci, Mol Pharmacol Lab, Kanazawa, Ishikawa, Japan
来源：
JOURNAL OF NEUROCHEMISTRY | 2013年 / 125卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：151 / 152
页数：2
相关论文
共 50 条
  • [1] Promoted Neuronal Differentiation after Activation of Alpha4/Beta2 Nicotinic Acetylcholine Receptors in Undifferentiated Neural Progenitors
    Takarada, Takeshi
    Nakamichi, Noritaka
    Kitajima, Seiya
    Fukumori, Ryo
    Nakazato, Ryota
    Nguyen Quynh Le
    Kim, Yeong-Hun
    Fujikawa, Koichi
    Kou, Miki
    Yoneda, Yukio
    PLOS ONE, 2012, 7 (10):
  • [2] Carboetomidate Inhibits Alpha4/Beta2 Neuronal Nicotinic Acetylcholine Receptors at Concentrations Affecting Animals
    Pierce, David W.
    Pejo, Ervin
    Raines, Douglas E.
    Forman, Stuart A.
    ANESTHESIA AND ANALGESIA, 2012, 115 (01): : 70 - 72
  • [3] Alpha4 and Beta2 Subunits of Neuronal Nicotinic Acetylcholine Receptor Genes Are Not Associated with Methamphetamine-Use Disorder in the Japanese Population
    Kishi, Taro
    Ikeda, Masashi
    Kitajima, Tsuyoshi
    Yamanouchi, Yoshio
    Kinoshita, Yoko
    Kawashima, Kunihiro
    Inada, Toshiya
    Harano, Mutsuo
    Komiyama, Tokutaro
    Hori, Toru
    Yamada, Mitsuhiko
    Iyo, Masaomi
    Sora, Ichiro
    Sekine, Yoshimoto
    Ozaki, Norio
    Ujike, Hiroshi
    Iwata, Nakao
    DRUG ADDICTION: RESEARCH FRONTIERS AND TREATMENT ADVANCES, 2008, 1139 : 70 - 82
  • [4] The Effects of Prenatal Stress on Alpha4 Beta2 and Alpha7 Hippocampal Nicotinic Acetylcholine Receptor Levels in Adult Offspring
    Schulz, Kalynn M.
    Andrud, Kristin M.
    Burke, Maria B.
    Pearson, Jennifer N.
    Kreisler, Alison D.
    Stevens, Karen E.
    Leonard, Sherry
    Adams, Catherine E.
    DEVELOPMENTAL NEUROBIOLOGY, 2013, 73 (11) : 806 - 814
  • [5] Alpha4 and beta2 genetic interaction. analysis of high affinity nicotinic receptor in schizophrenia
    Voineskos, S
    De Luca, V
    Wong, G
    King, N
    Kennedy, JL
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 44 - 44
  • [6] Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population
    Kishi, Taro
    Ikeda, Masashi
    Kitajima, Tsuyoshi
    Yamanouchi, Yoshio
    Kinoshita, Yoko
    Kawashima, Kunihiro
    Okochi, Tomo
    Inada, Toshiya
    Ozaki, Norio
    Iwata, Nakao
    JOURNAL OF NEURAL TRANSMISSION, 2008, 115 (10) : 1457 - 1461
  • [7] Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population
    Taro Kishi
    Masashi Ikeda
    Tsuyoshi Kitajima
    Yoshio Yamanouchi
    Yoko Kinoshita
    Kunihiro Kawashima
    Tomo Okochi
    Toshiya Inada
    Norio Ozaki
    Nakao Iwata
    Journal of Neural Transmission, 2008, 115 : 1457 - 1461
  • [8] Vagal nerve activity stimulates endo- and phagocytosis in intestinal and peritoneal macrophages via nicotinic acetylcholine receptor alpha4/beta2 in mice
    de Jonge, Wouter
    Heinsbroek, Sigrid
    van der Zanden, Esmerij P.
    Snoek, Susanne A.
    Cailotto, Cathy
    Boeckxstaens, Guy E.
    Greaves, David
    Gordon, Siamon
    GASTROENTEROLOGY, 2008, 134 (04) : A7 - A7
  • [9] Smoking in schizophrenia: Interaction analysis between ALPHA4 and BETA2 nicotinic subunit genes
    Voineskos, SH
    De Luca, V
    Wong, G
    Wong, A
    Kennedy, JL
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 229S - 229S
  • [10] Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects
    Nirogi, Ramakrishna
    Benade, Vijay
    Goyal, Vinod Kumar
    Pandey, Santosh Kumar
    Mohammed, Abdul Rasheed
    Shinde, Anil
    Dogiparti, Dhanunjay
    Ravula, Jyothsna
    Jetta, Satish
    Palacharla, Veera Raghava Chowdary
    CLINICAL DRUG INVESTIGATION, 2022, 42 (09) : 747 - 762
12345